Kythera Labs, a leader in healthcare data analytics and AI solutions, has partnered with Doceree, a pioneering platform for programmatic physician engagement, to deliver more precise, data-driven marketing and educational outreach to healthcare professionals. The collaboration combines Kythera’s advanced analytics capabilities with Doceree’s targeted advertising network to enable pharma and medtech companies to reach doctors with highly relevant content at the right time and place.
Glimpse:
Through this partnership, Kythera Labs will provide enriched, anonymized physician-level insights (specialty, prescribing patterns, patient demographics) while Doceree will activate those insights across its omnichannel programmatic ecosystem including web, mobile, EHR integrations, and point-of-care channels. The joint solution aims to improve HCP engagement rates, enhance message relevance, reduce wasted ad spend, and support better-informed prescribing decisions, with initial focus on high-value therapies in oncology, cardiology, and rare diseases.
Kythera Labs, a fast-growing healthcare analytics and AI company, has announced a strategic partnership with Doceree, the world’s first and largest programmatic advertising platform built exclusively for healthcare professionals. The collaboration, unveiled on February 27, 2026, brings together Kythera’s deep expertise in deriving actionable physician and patient insights from real-world data with Doceree’s sophisticated targeting and delivery capabilities across digital channels where doctors spend their professional time.
Under the partnership, Kythera Labs will supply Doceree with enriched, privacy-compliant physician-level data including specialty focus, prescribing behavior, patient population characteristics, and geographic practice patterns derived from anonymized claims, EHR, and other real-world sources. Doceree will then activate these insights through its omnichannel programmatic network, enabling pharma and medtech marketers to deliver highly personalized, contextually relevant content (educational materials, clinical updates, product information) directly to HCPs via web banners, mobile apps, EHR-embedded ads, point-of-care platforms, and video content during professional activities.
The joint solution addresses a key pain point in healthcare marketing: low engagement rates and wasted spend due to broad, non-targeted outreach. By combining Kythera’s granular analytics with Doceree’s precision delivery, the partnership promises significantly higher open and interaction rates, better message resonance, and stronger influence on clinical decision-making. Initial focus areas include high-value therapies in oncology, cardiology, immunology, and rare diseases, where physician education and timely information are critical for optimal patient outcomes.
Both companies emphasized strict adherence to privacy regulations (HIPAA in the U.S., DPDP Act in India) and ethical guidelines, with all data fully anonymized, consent-based where applicable, and used solely for professional engagement. The partnership will also include joint go-to-market efforts, co-developed case studies, and continuous performance optimization to demonstrate measurable ROI for clients in terms of improved HCP reach, engagement, and downstream prescribing behavior.
The announcement reflects the accelerating convergence of advanced data analytics and programmatic advertising in healthcare marketing, where precision and relevance are becoming essential to cut through information overload and drive meaningful clinical impact. Kythera Labs and Doceree plan to roll out the integrated solution to select pharma and medtech clients in the coming months, with broader availability targeted throughout 2026.
“Reaching the right doctor with the right message at the right time has always been the holy grail of healthcare marketing. This partnership finally makes it possible at scale smarter, faster, and more impactful than ever before.”
By
HB Team
Related News
